Tufts Medical Center has joined TriNetX’s research network to improve its clinical trial process, further expanding the company’s reach as it looks to grow internationally and introduce new offerings in 2018.
Watson for Clinical Trial Matching has shown an 80% increase in clinical trial enrollment at Mayo Clinic, which is expanding its partnership with IBM to further develop the cognitive computing platform.
Novartis hopes to eventually recruit ‘a significant portion’ of patients into a decentralized clinical trial model that has the potential to increase the company’s reach globally, says exec.
Novartis is expanding its strategic alliance with Science 37 and has committed to conducting up to 10 new clinical trials – blending both virtual and traditional models – over the next three years.
CTTI has completed more than 25 projects on issues affecting clinical trials over the past decade, since which time the industry has changed greatly, says executive director.
Apple has updated its Health app to give users access to their medical records – a new feature that could fundamentally change the way research is conducted, says Medidata.
Advertising, social media and individualised patient recruitment strategies can improve participation numbers according to clinical site executives, who say they favour a personalised approach.
Parexel has launched its first offering as part of its alliance with Microsoft, through which the companies are looking to redefine the life sciences industry, says CRO.
Science 37 and Otsuka Pharmaceutical have announced a strategic collaboration through which the global healthcare company aims to explore patient-centric clinical trials – “with fewer physical restrictions and greater efficiencies,” says CEO.
Transitioning to a single strategic contract research organization (CRO) reduced Bayer’s administrative burden, but the restructuring was met with some resistance, said the firm.
The industry is expected to use an increasing amount of real world evidence, including social media data, which will be used to support new drug applications, according to a recent Tufts report.
